LMR Partners’s Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share DNA.WS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-2,365,816
| Closed | -$43.8K | – | 1751 |
|
|
2024
Q2 | $66.7K | Hold |
2,365,816
| – | – | ﹤0.01% | 914 |
|
|
2024
Q1 | $213K | Hold |
2,365,816
| – | – | 0.01% | 860 |
|
|
2023
Q4 | $249K | Buy |
2,365,816
+954
| +0% | +$141 | 0.01% | 721 |
|
|
2023
Q3 | $532K | Buy |
2,364,862
+616,340
| +35% | +$166K | 0.01% | 551 |
|
|
2023
Q2 | $458K | Buy |
1,748,522
+516,072
| +42% | +$101K | 0.01% | 498 |
|
|
2023
Q1 | $1.64M | Buy |
1,232,450
+44,800
| +4% | +$10.3K | 0.03% | 477 |
|
|
2022
Q4 | $2.01M | Buy |
+1,187,650
| New | +$509K | 0.04% | 532 |
|
|
2022
Q2 | – | Sell |
-206,630
| Closed | -$833K | – | 1517 |
|
|
2022
Q1 | $833K | Sell |
206,630
-1,106,648
| -84% | -$1.23M | 0.01% | 874 |
|
|
2021
Q4 | $10.9M | Buy |
1,313,278
+1,155,911
| +735% | +$3.74M | 0.13% | 148 |
|
|
2021
Q3 | $1.82M | Buy |
+157,367
| New | +$560K | 0.02% | 485 |
|